The minimal inhibitory and minimal bactericidal concentrations of carbenicillin and gentamicin were determined for 10 strains of Pseudomonas aeruginosa isolated from the urinary tract. Combinations of the two drugs were tested for possible enhanced activity. Such enhancement was demonstrated in the inhibitory activity of combinations for eight strains. Striking bactericidal activity against five strains was achieved by the combination, whereas neither drug alone in low dosage was capable of bactericidal action. The possible mode of action and the possible merit of pursuing these preliminary findings are discussed.
Infections with Pseudomonas aeruginosa have become increasingly frequent in hospitalized patients, particularly if they receive antimicrobial drugs for prolonged periods. These organisms tend to produce chronic infection, particularly in persons with impaired host defenses (6, 10) . Although Pseudomonas infections often are indolent rather than fulminating, they present unique treatment problems because of the extraordinary resistance of these organisms to most antimicrobial drugs.
Most strains of P. aeruginosa are susceptible in vitro to polymyxins B and E, but in clinical usage the toxicity of these drugs often precludes their administration in sufficiently high dose for a sufficient period, and in systemic infections the response is often unsatisfactory. The advent of two new drugs active against Pseudomonas, gentamicin and carbenicillin, was therefore welcome. After an initial wave of enthusiastic reports (8, 11) , significant limitations of these drugs became apparent. Carbenicillin was effective against Pseudomonas only in very high concentrations (1, 10) , and resistance evolved rapidly (10) . Gentamicin resembled members of the neomycinkanamycin group in both activity and toxicity (5 Bacterial cultures. Ten strains of P. aeruginosa were employed which had originally been isolated from patient's urine and was used in an earlier study (4) . Agar slant cultures were kept at room temperature during the several months of the study. Inocula were prepared from cultures grown in Tryptose Phosphate Broth (Difco) overnight at 37 C.
Determination of antibacterial effect. Tubes containing various concentrations of antibiotics, singly or in combination, in 9.9 ml of Tryptose Phosphate Broth were inoculated with 0.1 ml of a dilution of an 18-hr broth culture of bacteria. The inoculum was adjusted to yield a concentration of about 101 organisms/ ml of test broth at the beginning of incubation. The initial number of organisms was determined by plate count of decimal dilutions on Heart Infusion Agar (Difco). To estimate the number of viable organisms, samples were removed from antibiotic-containing broth tubes after 24 and 48 hr at 37 C. Such 0.1-ml samples were spread over the surface of agar plates, and the number of colony-forming units was estimated after incubation.
The effective drug concentration was estimated either as the minimal inhibitory concentration (MIC), or as the minimal bactericidal concentration (MCC). Fig. 1 and 2) indicate that the addition of relatively low concentrations of gentamicin to barely bacteriostatic concentrations of carbenicillin resulted in rapid bactericidal effects. Undoubtedly, the small inoculum size reduced the likelihood of the emergence of resistance.
These results might warrant further exploration and perhaps might encourage clinical trial of this drug combination in suitable Pseudomonas infections. In these screening tests, no evidence of antagonism was observed. However, the protocols were not well suited for the detection of such an event.
DISCUSSION
Since Pseudomonas infection occurs particularly in individuals with impaired host defenses, bactericidal action of antimicrobial drugs should be preferable lo bacteriostatic action. Polymyxins are bactericidal for gram-negative bacteria in vitro, but their action in vivo is impeded by many different factors. As a result, tissue infections with Pseudomonas are virtually never eradicated by polymyxins (6, 7) . Alternative, and better, methods of treatment are urgently needed.
Carbenicillin can be markedly inhibitory for strains of Pseudomonas in concentrations that can be achieved readily in the urine and, with very high doses, also in tissues. Unfortunately, resistant mutants arise rapidly and regularly (4) Gentamicin is not known to exhibit cross-resistance with carbenicillin. As an aminoglycoside, the mode of action of gentamicin probably involves the control of protein synthesis at the ribosomal surface. By contrast, carbenicillin, like all penicillins, inhibits cell wall synthesis. The different modes of action of the two drugs suggest strongly that cross-resistance will probably not be found, although multiple-resistance transfer by means of episomes may be encountered. The diferent modes of action also suggest a possible explanation for the observed enhancement (synergism?) of combined carbenicillingentamicin action on Pseudomonas. The bactericidal efficacy of this combination against some strains may be particularly important in infected individuals with impaired antimicrobial defenses. The enhanced activity of carbenicillin-gentamicin combinations against some strains ofPseudomonas might also warrant clinical trial in those infections in which gentamicin, used singly, would have to be administered in large doses which might elicit undesirable side effects, whereas, in the combination a much smaller dose might be effective.
A different approach to the enhancement of carbenicillin action against P. aeruginosa might be the binding of the 3-lactamase produced by Pseudomonas with methicillin or an isoxazolylpenicillin (4, 9) . We attempted to show an enhancement of carbenicillin action against Pseudomonas by the simultaneous use of oxacillin at 500 jkg/ml, but only minimal enhancement was observed in screening tests. The results were even less encouraging than those reported earlier for ampicillin-oxacillin mixtures (4) , and therefore these attempts were abandoned.
